Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Blase

Showing results (441-450 of 466) with videos related to

Pageof 47
Sort By:
Diseases of the Colon and Rectum|September 8, 2018
Consolidation mFOLFOX6 Chemotherapy After Chemoradiotherapy Improves Survival in Patients With Locally Advanced Rectal Cancer: Final Results of a Multicenter Phase II TrialMichael R Marco, Lihong Zhou, Sujata Patil, et al.
Journal of Craniovertebral Junction & Spine|July 14, 2023
Reasons for transfer and subsequent outcomes among patients undergoing elective spine surgery at an orthopedic specialty hospitalTristan Blase Fried, Yunsoo Lee, Jeremy C Heard, et al.
JNCI Cancer Spectrum|April 8, 2020
Diabetes and Clinical Outcome in Patients With Metastatic Colorectal Cancer: CALGB 80405 (Alliance)Justin C Brown, Sui Zhang, Fang-Shu Ou, et al.
Gastroenterology|March 5, 2021
Therapeutic Interleukin-6 Trans-signaling Inhibition by Olamkicept (sgp130Fc) in Patients With Active Inflammatory Bowel DiseaseStefan Schreiber, Konrad Aden, Joana P Bernardes, et al.
Genome Medicine|September 24, 2022
Longitudinal multi-omics analysis identifies early blood-based predictors of anti-TNF therapy response in inflammatory bowel diseaseNeha Mishra, Konrad Aden, Johanna I Blase, et al.
Journal of Geriatric Oncology|February 2, 2022
Age and comorbidity association with survival outcomes in metastatic colorectal cancer: CALGB 80405 analysisNadine J McCleary, Sui Zhang, Chao Ma, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 14, 2019
Associations of Physical Activity With Survival and Progression in Metastatic Colorectal Cancer: Results From Cancer and Leukemia Group B (Alliance)/SWOG 80405Brendan J Guercio, Sui Zhang, Fang-Shu Ou, et al.
JNCI Cancer Spectrum|November 2, 2020
Body Mass Index and Weight Loss in Metastatic Colorectal Cancer in CALGB (Alliance)/SWOG 80405Brendan J Guercio, Sui Zhang, Alan P Venook, et al.
JAMA Network Open|October 30, 2020
Association of Diet Quality With Survival Among People With Metastatic Colorectal Cancer in the Cancer and Leukemia B and Southwest Oncology Group 80405 TrialErin L Van Blarigan, Sui Zhang, Fang-Shu Ou, et al.
JAMA|June 21, 2017
Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer: A Randomized Clinical TrialAlan P Venook, Donna Niedzwiecki, Heinz-Josef Lenz, et al.
Pageof 47

Showing results (441-450 of 466) with videos related to

Sort By:
Pageof 47
Diseases of the Colon and Rectum|September 8, 2018
Consolidation mFOLFOX6 Chemotherapy After Chemoradiotherapy Improves Survival in Patients With Locally Advanced Rectal Cancer: Final Results of a Multicenter Phase II TrialMichael R Marco, Lihong Zhou, Sujata Patil, et al.
Journal of Craniovertebral Junction & Spine|July 14, 2023
Reasons for transfer and subsequent outcomes among patients undergoing elective spine surgery at an orthopedic specialty hospitalTristan Blase Fried, Yunsoo Lee, Jeremy C Heard, et al.
JNCI Cancer Spectrum|April 8, 2020
Diabetes and Clinical Outcome in Patients With Metastatic Colorectal Cancer: CALGB 80405 (Alliance)Justin C Brown, Sui Zhang, Fang-Shu Ou, et al.
Gastroenterology|March 5, 2021
Therapeutic Interleukin-6 Trans-signaling Inhibition by Olamkicept (sgp130Fc) in Patients With Active Inflammatory Bowel DiseaseStefan Schreiber, Konrad Aden, Joana P Bernardes, et al.
Genome Medicine|September 24, 2022
Longitudinal multi-omics analysis identifies early blood-based predictors of anti-TNF therapy response in inflammatory bowel diseaseNeha Mishra, Konrad Aden, Johanna I Blase, et al.
Journal of Geriatric Oncology|February 2, 2022
Age and comorbidity association with survival outcomes in metastatic colorectal cancer: CALGB 80405 analysisNadine J McCleary, Sui Zhang, Chao Ma, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 14, 2019
Associations of Physical Activity With Survival and Progression in Metastatic Colorectal Cancer: Results From Cancer and Leukemia Group B (Alliance)/SWOG 80405Brendan J Guercio, Sui Zhang, Fang-Shu Ou, et al.
JNCI Cancer Spectrum|November 2, 2020
Body Mass Index and Weight Loss in Metastatic Colorectal Cancer in CALGB (Alliance)/SWOG 80405Brendan J Guercio, Sui Zhang, Alan P Venook, et al.
JAMA Network Open|October 30, 2020
Association of Diet Quality With Survival Among People With Metastatic Colorectal Cancer in the Cancer and Leukemia B and Southwest Oncology Group 80405 TrialErin L Van Blarigan, Sui Zhang, Fang-Shu Ou, et al.
JAMA|June 21, 2017
Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer: A Randomized Clinical TrialAlan P Venook, Donna Niedzwiecki, Heinz-Josef Lenz, et al.
Pageof 47